LaQuita Jones
Research Associate Professor-Affiliate · University of Cincinnati Medical Center Inc.
Credentials: · · · ·
History
Research
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
Science Translational Medicine · 2019 · 80 citations
Targeting AML-associated FLT3 mutations with a type I kinase inhibitor
Journal of Clinical Investigation · 2020 · First of 20 authors · 38 citations
Journal of Asthma · 2018 · 18 citations
3 papers
- CR
2 papers · 2 as a fellow
Dane Snyder
2 papers
2 papers
1 paper
1 paper
- AD
1 paper · 1 as a fellow
- AS
1 paper
Grants
- 2023–2028
Kinase-Independent Mechanism of Resistance to FLT3 Inhibitors in AML
National Cancer Institute · K08
Contact PI · $1M · Cincinnati Childrens Hosp Med Ctr
Clinical trials
- 2025–2028
Sub-investigator · Recruiting · Phase 2
Healx Limited